AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,575 | +82.5% | 137 | +87.7% | 0.00% | – |
| Q2 2023 | $5,246 | -8.5% | 73 | -21.5% | 0.00% | – |
| Q1 2023 | $5,736 | -89.8% | 93 | -87.2% | 0.00% | -100.0% |
| Q4 2022 | $56,074 | +1301.8% | 727 | +627.0% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 100 | -21.3% | 0.00% | – |
| Q1 2022 | $5,000 | -77.3% | 127 | -78.0% | 0.00% | -100.0% |
| Q4 2021 | $22,000 | +144.4% | 578 | +124.0% | 0.00% | – |
| Q3 2021 | $9,000 | +50.0% | 258 | +180.4% | 0.00% | – |
| Q2 2021 | $6,000 | +50.0% | 92 | +19.5% | 0.00% | – |
| Q1 2021 | $4,000 | +300.0% | 77 | +413.3% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 15 | +15.4% | 0.00% | – |
| Q3 2020 | $1,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |